Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Albuferon albumin-interferon alpha: Interim Phase IIb data

October 23, 2006 7:00 AM UTC

Interim quality of life data from an open-label, dose-ranging, international Phase IIb trial in 458 patients showed that Albuferon-treated groups recorded fewer missed work days and reported less impa...